DalsnaFinance

Invizix, Formerly Geminii Health Selected as Finalist in American Diabetes Association 2026 Innovation Challenge

Markets PR Newswire By PR Newswire 02 Jun 2026 13:04 1 min read
Invizix, Formerly Geminii Health Selected as Finalist in American Diabetes Association 2026 Innovation Challenge

Company was invited to present its sleep-time bioelectronic therapeutic platform at ADA Scientific Sessions in New Orleans CHICAGO, June 2, 2026 /PRNewswire/ -- Invizix, formerly Geminii Health, a company developing sleep-time bioelectronic therapies for age-related metabolism-driven...

Company was invited to present its sleep-time bioelectronic therapeutic platform at ADA Scientific Sessions in New Orleans CHICAGO, June 2, 2026 /PRNewswire/ -- Invizix, formerly Geminii Health, a company developing sleep-time bioelectronic therapies for age-related metabolism-driven...

Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.